Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business1 February 2016Corporate and M&A Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryUS firms top UK and global rankings in record year for M&A megadealsRevolving Doors: Willkie hires from Kirkland in Germany, while Slaughters London partner surfaces at SimmonsTrading places: Paul Weiss signs up five NY partners as Latham, Kirkland, A&O also make movesUS firms top UK and global rankings in record year for M&A megadealsTop US pair advise as Bridgepoint agrees to acquire KPMG spin-off InterpathHot markets and mega-deals: M&A partners on 2025 trends and hopes for the new yearRevolving doors: Simpson Thacher, Latham, Sidley lead New Year London moves‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryFive partners vie to succeed Hoyland as Simmons managing partner